Sysmex Europe Urinalysis

Exciting news! The revolutionary PA-100 AST System from #SysmexAstrego is now on display at the Science Museum in London! As ChallengeWorks, the awarder of the prestigious #LongitudePrize, stated, "Giving the right antibiotic as quickly as possible improves patient outcomes, not only in terms of the time it takes for symptoms to get better, but in terms of rare but significant complications like sepsis and hospital admissions." The PA-100 AST innovative system helps fight antibiotic resistance by identifying the presence of bacterial infection and guiding the right antibiotic choice within 45 minutes for uncomplicated UTIs. Faster targeted treatment means: 👉 Improved patient outcomes 👉 Reduced risk of complications 👉 More effective use of antibiotics Learn more about the PA-100 AST and its role in the fight against AMR here: https://lnkd.in/eDEeNfzj

“Dipstick-based urinalysis tests are on WHO's Essential Diagnostics List, but their sensitivity is typically less than 50%, making just-in-case prescribing of antibiotics likely.” The PA-100 AST System (Sysmex Astrego, Uppsala, Sweden) detects the presence of bacteria in urine in less than 15 min and susceptibility of the bacteria to five commonly prescribed antibiotics for the treatment of uncomplicated urinary tract infections in 45 min.” The lancet states: #AMR is a global challenge. As such, it must be tackled with the most advanced diagnostics. The #LongitudePrize recognised the great achievement accomplished by the #PA100 AST System in managing AMR in the context of UTI. Check the The Lancet Editorial “Navigating AMR with innovative diagnostics”: https://lnkd.in/dWCkH3Y9 Find more details about the PA-100 AST System: https://lnkd.in/eDEeNfzj

Check out last week’s BBC News live from the Longitude Prize ceremony at London’s Science Museum and learn more about how the #Sysmex PA-100 AST System is a game changer in the fight against Antimicrobial resistance #AMR🎥 #urinalysis

We're thrilled to share some impressions from the Longitude Prize ceremony in London! It was a huge honour to be recognised at the ceremony at the Science Museum London for our contribution to the fight against antimicrobial resistance. The PA-100 AST System is revolutionising rapid antibiotic susceptibility testing, delivering accurate results in under an hour. This empowers physicians to prescribe the right treatment faster, ultimately reducing the spread of #AMR. Read more about the PA-100 AST System and its impact here: https://lnkd.in/eTfupimk #Sysmex #LongitudePrize

It is an absolute honour to announce that Sysmex Astrego has been awarded the Longitude Prize on Antimicrobial Resistance #AMR for the PA-100 AST System. #UTI are a common affliction, but lack efficient diagnostics, resulting in increased AMR through inaccurate, empiric antibiotic prescriptions. #Sysmex Astrego’s user-friendly PA-100 AST System determines bacterial growth and radically expedites AST (antibiotic susceptibility tests) by having susceptibility results be available directly at the point-of-care in less than an hour. With the £8 million prize, we will continue combatting the global threat of AMR by not only pushing its production and distribution in Europe, but also further developing the technology and expanding its accessibility worldwide to critical regions. Sysmex Astrego is excited to continue further innovations and advancements with the PA-100 AST System. The road is clear and the future is bright! Learn more about the PA-100 AST System here👇 https://lnkd.in/eDEeNfzj #urinalysis

Have you met Sysmex Astrego yet?👀 Sysmex Astrego is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. The company was founded as Astrego Diagnostics AB in March 2017 with the mission to help in the global fight against antimicrobial resistance #AMR. Astrego Diagnostics was acquired by Sysmex Corporation, Japan in May 2022. The company name comes from Antibiotic Susceptibility Testing – AST, and rego – being latin for guide, steer or manage. Our products are designed to guide physicians in the selection of effective antibiotic treatments to improve patient outcomes and simplify antibiotic stewardship. #Sysmex #AST

Last Friday and Saturday, our colleagues from Sysmex España organised a workshop about #UTI and #AMR at a local nephrourology meeting in La Rioja, Spain. The workshop focused on antibiotic treatment and resistance to antimicrobials, “a global health problem due to the often-unnecessary use of antibiotics”, as stated by the speakers. They will test the PA-100 #AST System in their health centres, of which they shared that it is “a novel technology that offers fast and relevant information to the clinician to provide a better treatment to patients”. #sysmex #urinalysis

The PA-100 AST System offers the possibility of analysing native urine samples using a point of care tool. This automated analyser allows the detection of bacteriuria within 15 minutes and the performance of antibiotic susceptibility testing within 30 to 45 minutes. This will open the door to supporting for diagnoses that enable targeted antibiotic prescriptions within less than one hour, during the patient’s first visit to the doctor. Discover more about this powerful point of care tool here: https://lnkd.in/dMRScP-G #AST #AMR #antibioticresistance

May is bladder cancer awareness month, a time to raise awareness about this often-overlooked type of cancer. Bladder cancer occurs when abnormal cells in the bladder grow out of control. If detected early, bladder cancer can often be treated successfully, but unfortunately, many cases are not diagnosed until the cancer has advanced to a more serious stage. If you would like to educate yourself about the risk factors, symptoms, diagnosis, and treatment options for bladder cancer, please visit our dedicated website! 👇 https://lnkd.in/e9EGzdBW Join us in raising awareness about #bladdercancer and support those affected by it. #BladderCancerAwarenessMonth #EarlyDetectionSavesLives #Urinalysis #Sysmex

It is estimated that 150 million urinary tract infections (UTIs) occur yearly on a global basis, making it one of the most frequent bacterial infections worldwide. For everyday infections like UTIs, the possibility of a near-patient testing device provides a unique tool to select antibiotics tailored to each infectious episode. Making this information available to the treating expert and so close to the patient is key in the fight against antimicrobial resistance (#AMR) as well as helping patients recover faster. This is where the PA-100 AST System comes in. Learn more about #UTI and how Sysmex is guiding the future of antibiotic treatment: https://lnkd.in/ePrcm_HU #AST